Writing group for the Kids to Adults Working Group and Data Management and Harmonisation Group in EuroCoord. Children
and young people with perinatal HIV in Europe: epidemiological
situation in 2014 and implications for the future. Euro Surveill
2016;21(10)Lien PubMed
Fonsart J, Saragosti S,
Taouk M, Peytavin G, Bushman L, Charreau I, Hance A, Goldwirt L, Morel
S, Mammano F, Loze B, Capitant C, Clavel F, Mahjoub N, Meyer L, Anderson
PL, Delaugerre C, Molina JM. Single-dose
pharmacokinetics and pharmacodynamics of oral tenofovir and
emtricitabine in blood, saliva and rectal tissue: a sub-study of the
ANRS IPERGAY trial. J Antimicrob Chemother. 2016 Sep 28 Lien PubMed
BR
EATHER (PENTA 16) Trial Group. Weekends-off
efavirenz-based antiretroviral therapy in HIV-infected children,
adolescents, and young adults (BREATHER): a randomised, open-label,
non-inferiority, phase 2/3 trial.Lancet HIV. 2016 Sep 3 Lien PubMed
Barrail-Tran, Vincent C,
Furlan V, Rosa I, Rosenthal E, Cheret A, Molina JM, Taburet AKheloufi F,
Bellissant E, Cotte L, Poizot-Martin I, Quaranta S, Garraffo R,
Barrail-Tran A, Renault A, Fournier I, Lacarelle B, Bourlière M, Molina
JM, Solas C; ANRS HC27 BOCEPREVIH & HC26 TELAPREVIH Study Groups. Estimated
glomerular filtration rate but not solute carrier polymorphisms
influences anemia in HIV-hepatitis C virus coinfected patients treated
with boceprevir or telaprevir-based therapy. AIDS. 2016 Aug 24 Lien PubMed
Kheloufi
F, Bellissant E, Cotte L, Poizot-Martin I, Quaranta S, Garraffo R,
Barrail-Tran A, Renault A, Fournier I, Lacarelle B, Bourlière M, Molina
JM, Solas C; ANRS HC27 BOCEPREVIH & HC26 TELAPREVIH Study Groups. Estimated
glomerular filtration rate but not solute carrier polymorphisms
influences anemia in HIV-hepatitis C virus coinfected patients treated
with boceprevir or telaprevir-based therapy. AIDS 2016 Aug 23 Lien PubMed
Marcellin F, Fournier I, Carrieri MP,Poizot-Martin I, Cotte L; and the ANRS HC26 & ANRSHC27 Study Groups. From
first-generation HCV protease inhibitors to direct-acting antivirals:
self-reported symptoms as a warning signal for potential adverse events
(ANRS HC26, ANRS HC27 trials); Eur J Gastroenterol Hepatol. 2016 Jun Lien PubMed
Ananworanich J, Melvin D,
Amador JT, Childs T, Medin G, Boscolo V, Compagnucci A, Kanjanavanit S,
Montero S, Gibb DM; PENTA 11 Study Group. Neurocognition
and quality of life after reinitiating antiretroviral therapy in
children randomized to planned treatment interruption. AIDS 2016 Apr 24 Lien PubMed
De Castro N, Braun J,
Charreau I, Lafeuillade A, Viard JP, AllavenaC, Aboulker JP, Molina JM
and The EASIER ANRS 138 study group. Incidence and
risk factors for liver enzymes elevations in highly
treatment-experienced patients switching from enfuvirtide to
raltegravir: a sub-study of the ANRS-138 EASIER trial. AIDS Res Ther. 2016 Apr 2 Lien PubMed
Sagaon-Teyssier L,
Suzan-Monti M, Demoulin B, Capitant C, Lorente N, Préau M, Mora M, Rojas
Castro D, Chidiac, Chas, Meyer, Molina JM, Spire B; ANRS IPERGAY Study
Group. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. AIDS Care. 2016 Feb 17 Lien PubMed